ABACHEM(300261)2024-08-26 12:41Financial Performance - The company's operating revenue for the current period is ¥589,162,660.11, a decrease of 30.88% compared to ¥852,436,152.06 in the same period last year[11]. - The net profit attributable to shareholders of the listed company is -¥52,013,609.55, representing a decline of 153.77% from ¥96,741,250.66 in the previous year[11]. - The net cash flow from operating activities is ¥70,954,649.74, down 32.55% from ¥105,189,611.96 in the same period last year[11]. - The total assets at the end of the current period are ¥4,174,874,999.78, an increase of 0.72% from ¥4,145,222,725.41 at the end of the previous year[11]. - The weighted average return on equity is -2.28%, down from 3.96% in the previous year[11]. - The company reported a total net profit of -¥2,593,418.40 from non-recurring gains and losses during the reporting period[14]. - In the first half of 2024, the company achieved total operating revenue of CNY 58,916.27 million, a year-on-year decrease of 30.88%[20]. - The net profit attributable to shareholders in the first half of 2024 was CNY -5,201.36 million, reflecting a year-on-year decline of 153.77%[20]. - The company reported a significant decrease in investment amount to ¥6,500,000.00, down 90.71% from ¥70,000,000.00 in the same period last year[35]. Dividend Distribution - The company plans to distribute a cash dividend of 0.5 RMB per 10 shares to all shareholders, based on a total of 963,309,471 shares[1]. - The total cash dividend amounting to RMB 48,165,473.55, which represents 100% of the distributable profit[70]. - The total number of shares for the cash dividend distribution is based on 963,309,471 shares[71]. Risk Management - The report emphasizes the importance of risk awareness for investors regarding forward-looking statements and potential discrepancies between plans and commitments[1]. - The company has detailed potential risks and countermeasures in the section "Risks and Responses" of the management discussion and analysis[1]. - The company is facing industry demand fluctuation risks due to a "de-inventory" phase in the pesticide market, leading to reduced orders and pressure on operating performance[64]. - The company has acknowledged goodwill impairment risks due to significant acquisitions, which could adversely affect operating performance if acquired companies do not achieve expected returns[65]. - The company is exposed to exchange rate risks due to a significant portion of its business being settled in USD, which may fluctuate with changes in the political and economic environment[66]. Research and Development - The company focuses on the R&D, production, and sales of innovative pesticide intermediates and pharmaceutical intermediates[18]. - Research and development investment decreased by 34.76% to ¥38,932,933.54 from ¥59,675,767.29 in the previous year, indicating a reduction in R&D activities[27]. - The company has officially launched its fourth R&D center in Lanzhou, focusing on the development of antiviral drug intermediates[22]. - The company is actively investing in new product development and technological advancements to maintain competitive advantage[156]. Environmental Compliance - The company adheres to strict environmental protection laws and standards, ensuring compliance in its production processes[75]. - The total discharge of COD is reported at 1.3804 tons, with a total allowable discharge of 15.897 tons, indicating compliance with pollution discharge standards[76]. - The company has established environmental protection management systems, including wastewater discharge management regulations and emergency response plans for pollution incidents[86]. - The company has implemented a real-time monitoring system for wastewater and air emissions, ensuring compliance with environmental standards[87]. - The company has received a pollution discharge permit and has consistently paid the discharge fees, ensuring that pollutant emissions meet total control requirements[91]. Corporate Governance - The company has not experienced any changes in its registration status during the reporting period[10]. - The company has not engaged in entrusted financial management, derivative investments, or entrusted loans during the reporting period[53]. - The company has committed to avoiding competition and ensuring consistent decision-making among major shareholders[97]. - The company has not reported any significant contracts or leasing matters that would impact profits by more than 10%[111]. Subsidiaries and Investments - The company has 22 subsidiaries included in the consolidated financial statements, with one new addition and one cancellation compared to the previous year[161]. - The subsidiary Shanghai Yab Chemical Co., Ltd. reported a net profit of -0.43934 million CNY, while Nantong Yab Chemical Co., Ltd. reported a net profit of -3.20527 million CNY[55]. - The company is focusing on expanding its market presence through the establishment of new subsidiaries, such as Shanghai Shanyan New Energy Technology Co., Ltd., which had no significant impact on overall operations in the first half of 2024[56]. Financial Position - Total assets as of June 30, 2024, amounted to RMB 85,006.21 million, with net assets of RMB 26,451.64 million and a net profit of RMB 285.08 million[56]. - The company reported a total asset value of RMB 172,381.83 million for Nantong Yab Chemical Co., Ltd., with a net loss of RMB 3,205.27 million[58]. - The total liabilities at the end of the period were 689,070,497.40[151]. - The total equity attributable to shareholders of the parent company was CNY 2,264,990,537.12, down from CNY 2,274,817,267.89, a decrease of 0.4%[138]. Shareholder Information - The employee stock ownership plan involves 52 employees holding a total of 8,623,900 shares, accounting for 0.90% of the company's total share capital[72]. - The company completed a non-trading transfer of 8.6239 million shares to the employee stock ownership plan, effective January 31, 2024[74]. - The number of ordinary shareholders at the end of the reporting period was 65,623[123]. - Ningbo Yabao Holdings Co., Ltd. holds 26.75% of the shares, totaling 257,729,839 shares, with 96,680,000 shares pledged[123]. Legal and Regulatory Matters - The company has not experienced any penalties or rectifications during the reporting period[102]. - A total of 48 cases related to securities false statements resulted in a payment of approximately 2.59 million yuan, which will not significantly impact the financial report[101]. - The company has settled 14 cases related to securities false statements with a total payment of approximately 877,363.49 yuan, which will not significantly impact the financial report[101].